Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD). It contains an inhaled corticosteroid called ...

namely maintenance treatment for asthma and chronic obstructive pulmonary disease (COPD). Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the ...

Symbicort was first FDA-approved in 2006 as a treatment for asthma, followed by an extension to its label covering COPD in 2009. A further approval in 2017 in childhood asthma has helped the drug ...

inhaler for both Maintenance And Relief Therapy for moderate to severe asthma, or SMART. In the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera ...

Iconovo AB (publ), which develops complete inhalation products for a global market, today announced that the European Patent Office (EPO) intends to approve the company's application for a patent for ...